Page last updated: 2024-11-13

endo-ethenotetrahydrooripavine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

endo-ethenotetrahydrooripavine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21122112
MeSH IDM0113819

Synonyms (9)

Synonym
mcv 4438
endo-ethenotetrahydrooripavine
6,14-ethenomorphinan-3-ol, 7-amino-4,5-epoxy-6-methoxy-17-methyl-, (5alpha,7alpha)-
7alpha-amino-6,14-endo-ethenotetrahydrooripavine
nih 10093
eetho
87453-63-2
DTXSID301007571
(1r,2s,6r,14r,15r,19s)-19-amino-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]